Moleculin Biotech Inc (MBRX)
5.08
+0.05
(+0.99%)
USD |
NASDAQ |
May 17, 16:00
5.08
0.00 (0.00%)
After-Hours: 20:00
Moleculin Biotech Total Assets (Quarterly): 30.84M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 30.84M |
December 31, 2023 | 38.22M |
September 30, 2023 | 39.52M |
June 30, 2023 | 47.12M |
March 31, 2023 | 51.06M |
December 31, 2022 | 57.42M |
September 30, 2022 | 65.37M |
June 30, 2022 | 73.26M |
March 31, 2022 | 78.80M |
December 31, 2021 | 84.09M |
September 30, 2021 | 88.70M |
June 30, 2021 | 93.53M |
March 31, 2021 | 99.78M |
December 31, 2020 | 29.03M |
September 30, 2020 | 27.14M |
June 30, 2020 | 31.38M |
March 31, 2020 | 25.47M |
Date | Value |
---|---|
December 31, 2019 | 25.24M |
September 30, 2019 | 30.40M |
June 30, 2019 | 31.85M |
March 31, 2019 | 21.30M |
December 31, 2018 | 19.58M |
September 30, 2018 | 20.90M |
June 30, 2018 | 24.07M |
March 31, 2018 | 24.93M |
December 31, 2017 | 19.48M |
September 30, 2017 | 20.63M |
June 30, 2017 | 21.25M |
March 31, 2017 | 20.32M |
December 31, 2016 | 16.39M |
September 30, 2016 | 17.57M |
June 30, 2016 | 19.23M |
March 31, 2016 | 0.2897M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
25.24M
Minimum
Dec 2019
99.78M
Maximum
Mar 2021
52.41M
Average
43.32M
Median
Total Assets (Quarterly) Benchmarks
Merck & Co Inc | 105.85B |
Lixte Biotechnology Holdings Inc | 3.589M |
Moderna Inc | 16.73B |
NovaBay Pharmaceuticals Inc | 5.357M |
Palatin Technologies Inc | 11.41M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 9.258M |
Shareholders Equity (Quarterly) | 21.59M |